Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and ...

Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus ...

Global Phase 2b clinical trial underway evaluating rhu-pGSN for the treatment of moderate to severe ARDS. NORTH BRUNSWICK, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics ...

The economic, commercial, and financial blockade that the United States has maintained against Cuba for more than six decades ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

Oryzon is glad to participate as Sponsor of the congress ...

During World War I, people actually got poisoned eating rhubarb leaves when food was scarce. The beautiful red stalks are ...

The One-Click Dossier streamlines the production of high quality regulatory documents, such as Clinical Study Reports (CSRs), patient narratives, summaries, and others in a fully automated workflow.

Marvel Phase 6 is set to change everything for the MCU. This new era includes the introduction of some major characters like Fantastic Four, Robert Downey Jr. returning to play supervillain Doctor ...

Biogen has started a new phase 3 trial that aims to extend the use of its Friedreich's ataxia drug Skyclarys to patients as young as two.

Aridis Pharmaceuticals Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat ...